Financials
Financial year 2025
Pinxten Pharma Consulting from Peer, company number BE1020316472, closed financial year 2025 with a result of € 40,866 after tax. For that financial year Pinxten Pharma Consulting recorded a gross margin of € 63,790 and equity of € 42,866. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.
€ 42,866
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 40,866
Profit after tax over the fiscal year.
€ 47,610
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 40,866.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 40,309
Of which on lease € 40,309.
Debts at end 2025
€ 36,056
€ 7,758 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 1,751
Supplier invoices still open on the last day of the fiscal year.
€ 27,222
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to Pinxten Pharma Consulting?
What happened at Pinxten Pharma Consulting in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 40,866. Source: NBB ↗
- New establishment in Peer. KBO
- Lars Pinxten became a director. NBB
- Start of the company according to the CBE. KBO
In short
Paid € 11,672 in corporate taxes since 2025.
A new publication or filing at Pinxten Pharma Consulting? We notify you, reason included.
Follow Pinxten Pharma ConsultingDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Pinxten Pharma Consulting is Lars Pinxten.
Directors
According to the 2025 annual accounts
Lars Pinxten
Director
since 2025
Establishments
Establishment units
Physical locations of this company
Kleine Ambachtslaan 10
3990 Peer
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1020.316.472
- VAT number
- BE 1020.316.472
- Registered office
- Kleine Ambachtslaan 10, 3990 Peer
- Names & denominations
- Pinxten Pharma Consulting
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 February 2025
- Peppol
- Active · Active since 8 Apr 2025
- Activities · NACE
Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten
Overige diensten op het gebied van informatietechnologie en computer
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Activiteiten van ingenieurs en aanverwante technische adviseurs, exclusief landmeters-experts
Overige dienstverlenende activiteiten op het gebied van informatie
Overige zakelijke dienstverlening, neg